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The Prader–Willi syndrome (PWS) region contains several genes transcribed from the paternal chromosome only. We have previously identified
a testis-specific gene, C15orf2, which maps between NDN and SNURF-SNRPN and is expressed from both alleles. Here we report on two novel
genes (prader-willi region non-protein-coding RNA 1 and 2) located between NDN and C15orf2. By database search we found five partially
duplicated copies, of which only one of each appears to be active. PWRN2 is expressed only in testis and is biallelic. PWRN1 is biallelically
expressed in testis and kidney, but monoallelically in fetal brain. Methylation analysis of a CpG island 15 kb upstream of exon 1 showed absence of
methylation in spermatozoa, but methylated and unmethylated alleles in fetal brain. Reinvestigation of C15orf2 revealed that this gene is also
expressed in fetal brain and that expression in this tissue is monoallelic. We conclude that PWRN1 and C15orf2 may play a role in PWS.
© 2007 Elsevier Inc. All rights reserved.Keywords: Prader–Willi syndrome; imprinting; DNA methylationPrader–Willi syndrome (PWS) is a neurogenetic disorder
that results from the loss of paternal contribution of a 1.5-Mb
imprinted region on the proximal long arm of chromosome 15.
PWS is characterized by neonatal muscular hypotonia and
failure to thrive, hyperphagia and obesity starting in early
childhood, and hypogonadism, short stature, small hands and
feet, sleep apnea, behavioral problems, and mild to moderate
mental retardation. The PWS phenotype results from a 3- to 4-
Mb deletion affecting the entire imprinted domain on the
paternal chromosome, maternal uniparental disomy, or an
imprinting defect leading to maternal imprint on the paternal
chromosome. All three lesions lead to the lack of expression of
imprinted genes that are active on the paternal chromosome
only. So far four protein coding genes that are transcribed from
the paternal chromosome only (MKRN3, MAGEL2, NDN, and
SNURF-SNRPN) have been identified. Noncoding alternative
transcripts of the SNURF-SNRPN gene have been shown to⁎ Corresponding author. Fax: +49 201 723 5900.
E-mail address: karin.buiting@uni-due.de (K. Buiting).
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doi:10.1016/j.ygeno.2006.12.008serve as a host for several snoRNA genes. Most of the
paternally expressed genes are associated with a differentially
methylated region, which is methylated on the maternal
chromosome. The paternally expressed snoRNA genes located
in introns of SNURF-SNRPN lack a direct methylation imprint.
These snoRNAs are expressed from the paternal allele only,
because they are processed from the paternally expressed
SNURF-SNRPN transcript [1]. Thus, imprinted expression of
the snoRNAs is regulated indirectly through SNURF-SNRPN
methylation. The contribution to the PWS phenotype of any of
these genes is unknown, and it is still a matter of debate whether
PWS is caused by the loss of function of a single gene or of
several genes. Also it is not clear whether all genes in the PWS/
Angelman syndrome (AS) region have been detected.
In 2000 we identified an intronless gene (C15orf2) between
SNRPN and NDN, which encodes an 1156-amino-acid protein
of unknown function [2]. By Northern blot analysis we had
found that C15orf2 is exclusively expressed in testis. Biallelic
expression of C15orf2 in adult testis correlated with the absence
of methylation of a 250-bp CpG island. Here we report the
589K. Buiting et al. / Genomics 89 (2007) 588–595identification of two novel, non-protein-coding genes between
NDN and C15orf2. Expression analysis of C15orf2 and one
of the novel transcripts suggests that these two genes may be
imprinted in fetal brain.
Results
Identification of two noncoding alternatively spliced
transcripts
To identify novel transcripts in the 1-Mb region between
NDN and C15orf2 (Fig. 1A) we performed a computer-based
search for expressed sequences using the NCBI database (http://
www.ncbi.nlm.nih.gov/) and the Ensembl Human GenomeFig. 1. Physical maps. (A) Schematic overview of the chromosomal region 15q11–q1
genes expressed from the maternal chromosome only; black boxes, genes expresse
which are described in this paper. Orientation of transcription, if known, is indicated
Not drawn to scale. (B) Map of the 700-kb region centromeric to C15orf2 (green box
the overlapping PAC clones AC021439, AC087474, AC087463, AC139362, AC1391
their duplicons are drawn as yellow vertical bars. The three exons of PWRN2 and thei
given by a horizontal arrow. Black vertical bars, duplicated copies of the marker D15Server (http://www.ensembl.org). By this we identified two
EST clusters. Both clusters contain spliced transcripts, and each
cluster represents one gene. By sequence analysis of 15
overlapping EST and 17 RT-PCR clones from one gene
(PWRN1, prader-willi region non-protein-coding RNA 1) we
identified 26 exons (Supplementary Fig. 1). This gene spans a
genomic region of 160 kb. The 26 exons are located on the
overlapping PAC clones AC139362, AC139147, and
AC100720 with the most 3′ end 20 kb upstream of C15orf2.
The EST cluster representing the second gene (PWRN2, prader-
willi region non-protein-coding RNA 2) consists of 17 over-
lapping ESTs, which span 7.2 kb of genomic DNA located on
PAC clone AC087474 (Supplementary Fig. 2). By analyzing
the EST sequences and one RT-PCR product from human testis3. Blue boxes, genes expressed from the paternal chromosome only; red boxes,
d from both chromosomes; open boxes, genes PWRN1, PWRN2, and C15orf2,
by horizontal arrowheads. Vertical lines, snoRNA genes. IC, imprinting center.
). The novel genes PWRN1 and PWRN2 and the duplicated copies are located on
47, and AC100720 (from centromere to telomere). The 26 exons of PWRN1 and
r duplicated copies are drawn as blue vertical bars. Orientation of transcription is
S817. Gray vertical bars, duplicated copies of the anonymous sequence IR4-3R.
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transcripts are subject to alternative splicing and polyadenyla-
tion and have no protein-coding potential.
Complex pattern of duplication
Detailed BLAST searches (NCBI) of exonic and intronic
sequences revealed a complex pattern of duplications of both
genes. In addition to the PWRN1 copy represented by the EST
clones and RT-PCR products mentioned above, we found five
partial duplications of PWRN1 with sequence similarities
between 93 and 97% containing exons 10–20, exons 2–20
(lacking exons 14–18), exons 2–13 (lacking exon 7), exons 1–
20 (lacking exons 7–9), and exons 15, 16, 17, and 20 in a 700-
kb genomic region upstream of C15orf2 (see Fig. 1B). Several
copies of single PWRN1 exons, especially four single copies of
exon 1, were also found.
PWRN2was found to occur in five copies (sequence similarity
of 93–97%). All copies are located between exons 12 and 13 of
PWRN1 on the opposite strand. Two of the copies lack exon 3 and
the most centromeric copy contains only exon 1 in close
proximity to exon 13 of PWRN1.Although the duplicated copies
share a high degree of sequence similarity, there are several
diagnostic sequence differences between them. By employing
these differences, we could assign all of the EST and RT-PCR
clones to the PWRN1 and PWRN2 copies indicated in Fig. 1B.
Thus, only these copies appear to be expressed, although we
cannot exclude expression of the other copies at a very low level.
The duplicated region also contains several copies of two
polymorphic loci (IR4-3R and D15S817) [3,4]. By Southern
blot analysis of genomic DNA and YAC clones we had
previously obtained evidence for five copies of IR-4-3R [3]. By
sequence analysis we now know that it occurs in a total of seven
copies (Fig. 1B). Some of these are located between exons 13
and 14 of PWRN1, others are close to a single copy of exon 1.
D15S817 appears to occur in four copies.
Tissue-specific expression
The fact that the majority of EST clones found for PWRN1
and PWRN2 are derived from testis specific cDNA libraries
suggested that these transcripts are abundant in this tissue andFig. 2. Tissue-specific expression analysis of PWRN1 detectedlow in other tissues, although we obtained several RT-PCR
clones for PWRN1 from fetal brain (Supplementary Fig. 1). For
more detailed analysis of the tissue-specific expression patterns
we first performed RT-PCR for the most downstream exons of
PWRN1, which are not subject to duplication. We used RNA
from human blood, fibroblasts, and testis and additional 24
RNA samples contained in a commercially available RNA
panel. By RT-PCR we obtained a PCR product in human testis
only. However, after reamplification a PCR product in some
tissues (prostate, fetal brain, heart, kidney, liver, lung, skeletal
muscle, trachea, and spinal cord) was observed (Fig. 2). For
PWRN2 also we obtained an RT-PCR product in testis RNA
only. In contrast to PWRN1, reamplification gave no PCR
product in any other tissue tested.
DNA methylation analysis
By sequence analysis using the genome annotation package
NIX (http://www.hgmp.mrc.ac.uk/Registered/Webapp/nix/)
and the EMBOSS CpG plot software (http://www.ebi.ac.uk/
emboss/cpgplot/) we identified four CpG islands that were
339 bp (CpG1, AC139362, nucleotides 74804–75142), 227 bp
(CpG2, AC139362, nucleotides 125334–125560), 336 bp
(CpG3, AC087463, nucleotides 121473–121808), and 337 bp
(CpG4, AC087474, nucleotides 92508–92844) in size (see Fig.
1B). These CpG islands show 89.6 to 95.6% sequence identity,
indicating that they represent duplicated sequences (Supple-
mentary Fig. 3). One CpG island, CpG1, is located 15 kb
upstream of the first exon of PWRN1 and the remaining three
CpG islands seem to be duplicated together with one copy of
PWRN1 exon 1 (Fig. 3). To find out whether the tissue-specific
expression of PWRN1 is associated with methylation of CpG1,
we performed bisulfite sequencing in different tissues. Because
of the high sequence identity of the four CpG islands we were
not able to investigate each CpG island separately. Thus, we
established a common methylation-specific PCR (MS-PCR) for
all four CpG islands. MS-PCR was carried out on bisulfite-
treated DNA of human blood, fetal brain, and spermatozoa in
two PCRs for all four CpG islands, one with a primer pair
specific for the methylated DNA and another using a primer pair
specific for the unmethylated DNA. PCR products for
methylated and unmethylated DNA were obtained from DNAby reamplification of RT-PCR products for exons 23-26.
Fig. 3. Methylation states of the four duplicated CpG islands, GpG1–4, in human spermatozoa, peripheral blood, and fetal brain analyzed by bisulfite genomic
sequencing. The numbers on the left side of each row indicate the number of identical clones identified. See text for details. Filled circles, methylated cytosines; open
circles, unmethylated cytosines.
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spermatozoa only a PCR product for unmethylated DNA was
obtained. Amplification products were subcloned and a total of
197 clones (59 for spermatozoa, 67 for blood, and 71 for fetal
brain) were analyzed by sequencing. Sequence differences
between the four CpG islands were used to assign the clones to
the different islands (Fig. 3). CpG1 is unmethylated in
spermatozoa and blood. In fetal brain, equal proportions of
methylated and unmethylated sequences were found. CpG2,
CpG3, and CpG4 are unmethylated in spermatozoa, but
methylated at various degrees in blood and fetal brain.
Allelic expression analysis of PWRN1 and PWRN2
To investigate the imprinting status of the novel transcripts
we performed RT-PCR with the same primer pairs as for the
tissue-specific expression studies. To distinguish between
parental alleles we made use of expressed single nucleotide
polymorphisms (SNPs). For PWRN1 we analyzed an A to T
exchange in exon 26 (position 34585 in AC100720,
rs12908526) and for PWRN2 a G to T exchange in exon 2
(position 25618 in AC087474). For PWRN1 we performed RT-
PCR on RNA from three different human testis samples and one
kidney sample obtained from different individuals. DNA
samples were not available. Sequence analysis of the PWRN1
RT-PCR products revealed that two of the testis RNAs
contained the A allele only. In the third testis sample and in
the one kidney sample we detected both the A and the T allele,
indicating that PWRN1 is biallelically expressed in these tissues
(data not shown). The first two individuals may be homo-zygous, although we cannot exclude monoallelic expression.
For fetal brain we had DNA and RNA samples from eight
different individuals. Two individuals (fb112 and fb156) were
heterozygous at the DNA level. Sequence analysis of the RT-
PCR products of these two samples revealed the presence of the
T allele only in the fb112 RNA and the presence of the A allele
only in the fb156 RNA, indicating monoallelic expression of the
transcript in fetal brain (Fig. 4). Allele-specific expression was
confirmed by cloning and sequencing of the RT-PCR products.
For RNA sample fb112 we obtained 38 clones, all containing
the T allele, and for RNA sample 156 we obtained 38 clones, 35
of them containing the A allele and 3 containing the T allele.
Since parental DNA was not available for further studies we
could not distinguish if expression in fetal brain is restricted to
the maternal or paternal allele.
For PWRN2, for which expression was found only in testis
RNA, two testis RNA samples were investigated for the G/T
polymorphism in exon 2. One sample contained only the G
allele. The second sample contained both, the G and the T allele,
indicating that this transcript was expressed from both parental
alleles.
Monoallelic expression of C15orf2 in fetal brain
By Northern blot analysis we had found that C15orf2 is
expressed in testis only [2]. Since PWRN1, which maps 25 kb
upstream of C15orf2, showed most abundant expression in
testis, but low-level expression in other tissues also, we
investigated by RT-PCR whether low-level C15orf2 expression
can be detected in other tissues, especially in fetal brain. We
Fig. 4. Monoallelic expression of PWRN1. Sequence analysis of DNA samples
fb112 and fb156 from human fetal brain around a single nucleotide
polymorphism in exon 26 (rs12908526) revealed presence of an A and a T
allele. In RNA of fb112 only the Tallele and in RNA of fb156 only the A allele is
present.
592 K. Buiting et al. / Genomics 89 (2007) 588–595performed RT-PCR on RNA from fetal brain using two different
primer pairs, one for the coding region and the other for the 3′
untranslated region, and indeed observed PCR products of the
expected sizes (see Fig. 5A). Since C15orf2 is an intronless
gene, we performed RT-PCR for the β-actin locus to exclude
genomic contamination of the RNA. No unspliced product was
observed.
This finding raised the question whether in fetal brain
C15orf2 is monoallelically expressed, like PWRN1. To clarify
this question we made use of four known intragenic fragment
length polymorphisms (one dinucleotide and three tetranucleo-
tide repeats [2]). We first genotyped six fetal brain DNA
samples for four different intragenic polymorphisms in the 3′untranslated region (3′ UTR) of the gene. Three of the six DNA
samples studied (fb55, fb88, and fb154) were found to be
heterozygous for one tetranucleotide repeat inside the 3′ UTR
(position nt 5898, GenBank Accession No.AF179681). In all
three corresponding RNAs we could detect only one allele,
indicating that C15orf2 is monoallelically expressed in fetal
brain, similar to PWRN1 (Fig. 5B).
Discussion
We have identified two novel genes between NDN and
C15orf2. The genes occur in five copies in a 700-kb region (Fig.
1B), but only one copy each appears to be expressed. The genes
have no protein-coding potential and are subject to alternative
splicing and polyadenylation. In view of the presence of
snoRNA genes within the noncoding 3′ part of the SNURF-
SNRPN transcription unit [5] we searched the 160-kb PWRN1
locus for possible candidates for C/D box snoRNAs using a
computer-aided analysis, but we did not obtain any sequences
showing evidence for the presence of all sequences (C-, C′-, D′-,
and D-boxes) and structural motifs (short inverted repeats at
their 5′ and 3′ ends) of bona fide C/D box snoRNAs.
The expression of PWRN1 is most abundant in testis, but
also present at low levels in several other tissues, including fetal
brain. SNP analysis revealed biallelic expression of this
transcript in human testis and kidney, whereas in two
independent human fetal brain samples we detected monoallelic
expression of three different isoforms, two of which occur in
fetal brain only. Since parental DNA samples were not
available, we could not distinguish if expression is restricted
to the paternal or maternal allele.
We also found four duplicated copies of a CpG island, one of
which (termed CpG1) is located 15 kb upstream of exon 1 of
PWRN1. Methylation analysis of CpG1 showed complete
absence of methylation in DNA from human spermatozoa,
but an equal proportion of methylated and unmethylated alleles
in DNA from human fetal brain. Due to the absence of any
polymorphism close to or inside CpG1 we were not able to find
out whether methylation in fetal brain is allele specific.
However, monoallelic expression in this tissue suggests that
expression is regulated by differential DNA methylation. In
RNA from peripheral blood we could not detect any expression
of PWRN1, although CpG1 is unmethylated. A possible
explanation for these findings is that blood cells lack a
transcription factor for PWRN1.
As reported previously by us [2], C15orf2 encodes an
1156-amino-acid protein of unknown function, which is
present in primates only. In contrast to other genes in the
PWS/AS region, C15orf2 is conserved in other primates but
not in mice. Based on these findings we had suggested that
C15orf2 may play a role in primate spermatogenesis. This
notion has recently been substantiated by the finding that
C15orf2 harbors several genes for PIWI-interacting RNAs
(piRNAs), which are believed to regulate spermatogenesis [6–
9]. The data reported here suggest that C15orf2 may also have
a role in fetal brain. By comparing genes from humans with
their chimpanzee orthologues, Nielsen et al. [10] obtained
Fig. 5. Expression analysis of C15orf2 in human fetal brain. (A) RT-PCR for the coding region (left) and the 3′ UTR (right) of RNA from different fetal brain samples.
PCR products of the expected sizes of 160 and 170 bp, respectively, were obtained. (B) Monoallelic expression of C15orf2. Genotyping of three independent DNA
samples of human fetal brain, fb055, fb088, and fb154, revealed heterozygosity for a tetranucleotide polymorphism in the 3′ UTR of C15orf2, whereas in the three
corresponding RNA samples only one allele was present.
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13,731 annotated genes studied, C15orf2 had the sixth highest
score. Since we have now found that C15orf2 is expressed in
fetal brain and may be subject to genomic imprinting, we
cannot exclude a role for this gene in PWS.
Material and methods
Patients and tissues
Fetal brain samples were obtained from aborted fetuses, which underwent
pathological examination and cytogenetic analysis in the Pediatric Pathology
Department at Mainz University School of Medicine. Use of anonymized
“excess” tissue materials for scientific analyses was approved by the local ethicscommittee [Aerztekammer Rheinland-Pfalz, Decision No. 837.103.04 (4261)].
Gestational age of each fetus was determined by foot length measurements (in
mm) and last menstrual period [11]. Only fetuses without detectable abnormal
development and with normal karyotypes were selected for this study. Fetal
tissues were dissected within 24 h after abortion and stored at −80 °C until
further analysis.
Preparation of RNA and DNA
Total RNA from human blood and fibroblasts was isolated with the QIAamp
RNA Blood Mini kit (Qiagen). RNA and DNA from human fetal brain samples
were extracted using the NucleoSpin RNA II kit (Macherey and Nagel, Cat. No.
740955) in combination with the NucleoSpin RNA/DNA buffer set (Macherey
and Nagel, Cat. No. 740944). Furthermore, 24 RNA samples from the total RNA
master panel (BD Bioscience) were used.
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Eight DNA samples from human fetal brain were analyzed for
heterozygosity of an expressed SNP (rs12908526) in exon 26 of PWRN1
using primers Ex26SNPF, 5′-GGAACAAGTTTATTCACACACAGA-3′, and
Ex26SNPR, 5′-TGTCAACAGGGAAAGTGGAA-3′ (annealing 58 °C). Six
DNA samples were studied for heterozygosity of four polymorphic nucleotide
repeats in the 3′ untranslated region of C15orf2 as described by Färber et al.
[2].
cDNA analysis
PWRN1 and PWRN2 transcripts were isolated from Marathon-Ready
human testis and human fetal brain cDNA (BD Biosciences). PCR was
carried out with 0.5 ng cDNA in a total volume of 100 μl for 35 cycles of
denaturation (95 °C for 15 s), annealing (30 s; for annealing temperature see
different primer pairs), and extension (72 °C for 30 s). Reamplification was
performed with 5 μl of PCR products in a total volume of 50 μl using the
same PCR conditions. PCR products were verified by sequencing with PCR
primers. In the case of multiple PCR products, the products were cut from the
gel, purified with the MinElute Gel Extraction kit (Qiagen), and sequenced
directly or sequenced with vector-specific primers after subcloning into the
pGEM-T Easy vector (Promega). RT-PCR primer pairs used for PWRN1
werePWRN2-AK058147-F2, 5′-AACACGGAGATGCATTGACA-3′ and Ex26R,
5′-ACCTGGGCAACAATTGACTC-3′ (annealing 56 °C) (RT-1); PWRN1-
Exon19-F, 5′-GCAACATTCGAAACCCAGGTGCT-3′, and Ex26R, 5′-
ACCTGGGCAACAATTGACTC-3′ (annealing 61 °C) (RT-2); AK058147-F2,
5′-AACACGGAGATGCATTGACA-3′, and AL704599-R2, 5′-TCTG-
TTTCCCAAGCTGGAGT-3′ (annealing 60 °C) (RT-3); PWRN1-Exon2-F,
5′-GATTCCCCAGCT-GATCCTCG-3′ and PWRN1-Exon8-R, 5′-AGAAG-
GGTGTCAATGCATCACCG-3′ (annealing 63 °C) (RT-4-RT-15); Ex23F, 5′-
GCCTCCTTTATTGAGAAATGTTTT-3′ and Ex26R, 5′-ACCTGGGCAA-
CAATTGACTC-3′ (RT-16 and RT-17).
For PWRN2 the following primers were used: BI561478-F1, 5′-GCCCTTT-
AGTGGGGATCTGT-3′ and CD557156-R2, 5′-AAGCATGAAGGCTTGGA-
CAT-3′ (annealing 60 °C).
Tissue-specific expression analysis.
Total RNA (1 μg) was reverse transcribed with random hexamers. For
PWRN1 and PWRN2 RT-PCR was performed with the GeneAmp RNA PCR kit
(Perkin–Elmer). For PWRN1 we used primers for exon 23 (Ex23F, 5′-
GCCTCCTTTATTGAGAAATGTTTT-3′) and exon 26 (Ex26R, 5′-
ACCTGGGCAACAATTGACTC-3′). For PWRN2 we used primers for exon
1 (BI561478-F1, 5′-GCCCTTTAGTGGGGATCTGT-3′) and exon 2
(CD557156-R2, 5′-AAGCATGAAGGCTTGGACAT-3′). PCR on cDNA
products was carried out in a total volume of 50 μl for 35 cycles of denaturation
(95 °C for 15 s), annealing (62 °C for PWRN1 and 60 °C for PWRN2 for 30 s),
and extension (72 °C for 30 s). Reamplification was performed on 1 μl of the
original PCR sample using the same PCR conditions.
For reverse transcription of C15orf2, the reaction mixture containing 30 μg
of total RNA, 4 μl of random primer (Roche), and 4 μl of 5× reverse
transcriptase buffer (Invitrogen) was incubated for 10 min at 70 °C and then for
15 min at room temperature. After addition of 2 μl of dNTPs (5 mM each), 2 μl
of 0.1 M DTT, 0.5 μl of RNase inhibitor, and 1 μl of reverse transcriptase
(Invitrogen), the mixture was incubated for 2 h at 37 °C. Then 1 μl RNase H was
added and incubated for 20 min at 37 °C. The resulting cDNAwas purified with
a QIAquick PCR purification kit (Qiagen). Two sets of primers were used for
PCR: p1en47, 5′-TAGGGAGAAACCTCTAGTCTC-3′, and pGTRr2, 5′-
CTGGGCTAAGGCTCCGTC-3′ (annealing 58 °C), for the 3′ untranslated
region and pen2c, 5′-AGCCTGATCCGGCTGCA-3′, and pen2mr, 5′-AATA-
CAGAAAGGCTTCTCATC-3′ (annealing 56 °C), for the coding region of the
gene [2]. PCR was performed on 450 ng cDNA in a total volume of 50 μl for 35
cycles of denaturation (95 °C for 15 s), annealing (58 or 56 °C for 15 s), and
extension (72 °C for 30 s). In control experiments, reverse transcriptase or
cDNAwas omitted from the reactions. To check the integrity of the RNA and to
exclude contamination with genomic DNA we used primers for β-actin [12].Allelic expression analysis
To investigate allelic expression of PWRN1 and PWRN2, we used an
expressed SNP in exon 26 of PWRN1 and exon 2 of PWRN2. RT-PCR
conditions were as described for the tissue-specific expression analysis. The RT-
PCR products from human testis and kidney were analyzed by sequencing.
Allelic expression of PWRN1 in human fetal brain was investigated in two
heterozygous fetuses. Reverse transcription of the RNA was performed as
described above for C15orf2 (see previous paragraph). PCR products were
analyzed by direct sequencing. For both RNA samples fb112 and fb156 the PCR
products were cloned into the plasmid vector pGEM-T Easy (Promega) and
clones were sequenced using a vector-specific primer.
Allelic expression of C15orf2 in human fetal brain was studied in three
fetuses heterozygous for an intragenic tetranucleotide repeat (nt 5898, GenBank
Accession No. AF179681) [2]. PCR was carried out with primers pc313b, 5′-
ATGTTGTTTAAGCTACCAGTC-3′, and pc314rFAM, 5′-GCACCATTGCC-
TAAGGAA-3′ (annealing 56 °C). Fluorescence-tagged PCR products were
analyzed using an ABI 3100 automatic capillary genetic analyzer and GeneScan
and Genotyper software (Applied Biosystems).
Analysis of DNA methylation
Genomic DNA from human testis, spermatozoa, blood, and fibroblasts was
treated with sodium bisulfite according to standard methods. A 114-bp PCR
product was amplified in a common methylation-specific PCR for all four CpG
islands using primers CpG-all-FM, 5′-GGGACGACGATATAGGTAGGTATC-
3′, and CpG-all-RM, 5′-AATCTACAAAAAAACTCAAAACGAA-3′, for the
methylated DNA and CpG-all-FU, 5′-GGATGATGATATAGGTAGGTATTGT-
3′, and CpG-all-RU, 5′-AATCTACAAAAAAACTCAAAACAAA-3′, for the
unmethylated DNA (annealing temperature 58 °C). PCR products were gel-
purified using the MinElute Gel Extraction kit (Qiagen) and cloned into the
pGEM-T Easy vector (Promega). Plasmid clones obtained were sequenced with
the SP6 vector-specific primer.
Sequence analysis
Sequencing reactions were performed with fluorescence-tagged dideox-
ynucleotides (BIG Dye kit) and the Taq cycle sequencing procedure (ABI).
Sequences were analyzed on an ABI 3100 DNA sequencer.Acknowledgments
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